Shabana Mohammad Ali. “Safety of Dapagliflozinin Reducing Cardiac Events and Deaths Among NYHA Class II and III Cardiac Failure Patients”. Pakistan Journal of Medical & Health Sciences, vol. 18, no. 01, Apr. 2024, p. 35, doi:10.53350/pjmhs0202418135.